Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver T Keppler

Showing results (31-40 of 146) with videos related to

Pageof 15
Sort By:
Biomedicines|November 25, 2023
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization TestsJohannes Roessler, Dagmar Pich, Verena Krähling, et al.
Plos Pathogens|March 27, 2007
HIV-1 buds predominantly at the plasma membrane of primary human macrophagesSonja Welsch, Oliver T Keppler, Anja Habermann, et al.
The EMBO Journal|August 26, 2020
CARD8 inflammasome activation triggers pyroptosis in human T cellsAndreas Linder, Stefan Bauernfried, Yiming Cheng, et al.
Plos Pathogens|April 15, 2021
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infectionEzgi Akidil, Manuel Albanese, Alexander Buschle, et al.
Retrovirology|February 12, 2011
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 releaseHanna-Mari Tervo, Stefanie Homann, Ina Ambiel, et al.
Medical Microbiology and Immunology|January 10, 2016
Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD)Claudia Reinheimer, Anna Wesner, Oliver T Keppler, et al.
Journal of Virology|February 12, 2010
Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 VpuChristine Goffinet, Stefanie Homann, Ina Ambiel, et al.
BMC Infectious Diseases|March 15, 2017
Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive menClaudia Reinheimer, Oliver T Keppler, Christoph Stephan, et al.
The Journal of Biological Chemistry|May 12, 2006
The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activityClaudia Haller, Susanne Rauch, Nico Michel, et al.
Retrovirology|March 22, 2008
Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion densitySilvia Geuenich, Christine Goffinet, Stephanie Venzke, et al.
Pageof 15

Showing results (31-40 of 146) with videos related to

Sort By:
Pageof 15
Biomedicines|November 25, 2023
SARS-CoV-2 and Epstein-Barr Virus-like Particles Associate and Fuse with Extracellular Vesicles in Virus Neutralization TestsJohannes Roessler, Dagmar Pich, Verena Krähling, et al.
Plos Pathogens|March 27, 2007
HIV-1 buds predominantly at the plasma membrane of primary human macrophagesSonja Welsch, Oliver T Keppler, Anja Habermann, et al.
The EMBO Journal|August 26, 2020
CARD8 inflammasome activation triggers pyroptosis in human T cellsAndreas Linder, Stefan Bauernfried, Yiming Cheng, et al.
Plos Pathogens|April 15, 2021
Highly efficient CRISPR-Cas9-mediated gene knockout in primary human B cells for functional genetic studies of Epstein-Barr virus infectionEzgi Akidil, Manuel Albanese, Alexander Buschle, et al.
Retrovirology|February 12, 2011
β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 releaseHanna-Mari Tervo, Stefanie Homann, Ina Ambiel, et al.
Medical Microbiology and Immunology|January 10, 2016
Prevalence of K65R in patients treated with tenofovir disoproxil fumarate: recommendations based on the Frankfurt HIV Cohort Study Resistance Database (FHCS-RD)Claudia Reinheimer, Anna Wesner, Oliver T Keppler, et al.
Journal of Virology|February 12, 2010
Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 VpuChristine Goffinet, Stefanie Homann, Ina Ambiel, et al.
BMC Infectious Diseases|March 15, 2017
Elevated prevalence of multidrug-resistant gram-negative organisms in HIV positive menClaudia Reinheimer, Oliver T Keppler, Christoph Stephan, et al.
The Journal of Biological Chemistry|May 12, 2006
The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activityClaudia Haller, Susanne Rauch, Nico Michel, et al.
Retrovirology|March 22, 2008
Aqueous extracts from peppermint, sage and lemon balm leaves display potent anti-HIV-1 activity by increasing the virion densitySilvia Geuenich, Christine Goffinet, Stephanie Venzke, et al.
Pageof 15